Resolutions 1 to 9 (inclusive) were proposed as ordinary resolutions and resolution 10 was proposed as a special resolution.

The results of the poll are outlined in the table below.

Total Votes

% of

Resolution

For:

%age

Against:

%age

Cast

ISC

Withheld

1. to receive a copy of

the Annual Report for

the year ended 30 June

2020

556,845,254

100

0

0

556,845,254

87.03

26,857

2. To approve the

Directors' Remuneration

Report

554,801,389

99.64

1,990,053

0.36

556,791,442

87.02

80,669

3. To re-appoint Manuel

Llobet as a Director

556,845,611

100

0

0

556,845,611

87.03

26,500

4. To re-appoint Nicolas

Wykeman as a Director

556,821,111

99.99

25,000

0.01

556,846,111

87.03

26,000

5. To re-appoint Steve

Smith as a Director

554,199,787

99.53

2,636,967

0.47

556,836,754

87.02

35,357

6. To re-appoint Peter

Jensen as a Director

554,200,287

99.6

2,211,900

0.4

556,412,187

86.96

459,924

7. To re-appoint Grant

Thornton LLP as

auditors of the Company

554,851,201

99.64

2,007,553

0.36

556,858,754

87.03

13,357

8. To authorise the

Directors to determine

the Auditors

remuneration

556,787,942

99.99

25,000

0.01

556,812,942

87.02

59,169

9. To authorise the

Directors to allot the

unissued share capital

up to a specified amount

(s.551)

281,855,864

50.8

272,997,694

49.2

554,853,558

86.71

2,018,553

10. Special Resolution:

To disapply pre-emption

provisions of s.561(1) of

the Companies Act 2006

up to a specified amount

281,828,810

50.61

274,980,390

49.39

556,809,200

87.02

62,911

Attachments

  • Original document
  • Permalink

Disclaimer

Allergy Therapeutics plc published this content on 08 December 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 December 2020 21:08:04 UTC